Inactief instrument

Koers Islet Sciences Inc OTC Bulletin Board

Aandelen

slotkoers OTC Bulletin Board Andere beurzen
- ^USD	-

Islet Sciences, Inc. Publishes Data Supporting Remogliflozin Etabonate as a Potential Treatment for NAFLD and NASH	04-05-15
Islet Sciences, Inc. Presented at 50th International Liver Conference	23-04-15
Islet Sciences, Inc. COO to Present at Metabolic Leaders Forum	24-03-15
Islet Sciences, Inc. COO to Present at EASL: Remogliflozin Etabonate as Novel Treatment for Non-alcoholic Steatohepatitis (NASH)	09-03-15
Islet Sciences, Inc. Confirms Issuance of U.S. Patent for Using SGLT2 Inhibitors to Treat NASH/NAFLD	05-03-15

Sector

	Vaira. 1 jan.	Kapi.
IQVIA HOLDINGS INC.	+0,22%	42,86 mld.
MODERNA, INC.	+12,42%	42,74 mld.
LONZA GROUP AG	+44,30%	41,36 mld.
CELLTRION, INC.	-6,20%	27,68 mld.
ICON PUBLIC LIMITED COMPANY	+5,87%	25,15 mld.
ALNYLAM PHARMACEUTICALS, INC.	-23,68%	18,63 mld.
MEDPACE HOLDINGS, INC.	+27,12%	12,37 mld.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-3,60%	11,92 mld.
UNITED THERAPEUTICS CORPORATION	+7,16%	11,21 mld.